Join to View Full Profile
75 Francis StBoston, MA 02115
Dr. Mog is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins University School of MedicineClass of 2024
Certifications & Licensure
MA State Medical License 2024 - 2026
Publications & Presentations
PubMed
- 2 citationsPreclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.Brian J Mog, Nikita Marcou, Sarah R DiNapoli, Alexander H Pearlman, Tushar D Nichakawade
Science Translational Medicine. 2024-07-10 - 14 citationsTRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman
Nature. 2024-04-01 - 13 citationsHydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.Katharine M Wright, Sarah R DiNapoli, Michelle S Miller, P Aitana Azurmendi, Xiaowei Zhao
Nature Communications. 2023-08-21
Press Mentions
New Co-STAR T Cells Show Promise for Treating Cancers in Laboratory StudyJuly 11th, 2024- US Study Reveals Co-STAR Receptor Cells Show Promise in Treating CancersJuly 18th, 2024
- New Co-STAR Immunotherapy Receptor Shows Anti-Cancer EfficacyJuly 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
